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ABSTRACT:

The Saccharomyces cereVisiae high-mobility group protein HMO1 is composed of two DNAbinding domains termed box A and box B, of which only box B is predicted to adopt a HMG fold, and
a lysine-rich C-terminal extension. To assess the interaction between individual domains and their
contribution to DNA binding, several HMO1 variants were analyzed. Using circular dichroism spectroscopy,
thermal stability was measured. While the melting temperatures of HMO1-boxA and HMO1-boxB are
57.2 and 47.2 °C, respectively, HMO1-boxBC, containing box B and the entire C-terminal tail, melts at
46.1 °C, suggesting little interaction between box B and the tail. In contrast, full-length HMO1 exhibits
a single melting transition at 47.9 °C, indicating that interaction between box A and either box B or the
tail destabilizes this domain. As HMO1-boxAB, lacking only the lysine-rich C-terminal segment, exhibits
two melting transitions at 46.0 and 63.3 °C, we conclude that the destabilization of the box A domain
seen in full-length HMO1 is due primarily to its interaction with the lysine-rich tail. Determination of
DNA substrate specificity using electrophoretic mobility shift assays shows unexpectedly that the lysinerich tail does not increase DNA binding affinity but instead is required for DNA bending by full-length
HMO1; HMO1-boxBC, lacking the box A domain, also fails to bend DNA. In contrast, both HMO1 and
HMO1-boxAB, but not the individual HMG domains, exhibit preferred binding to constrained DNA
minicircles. Taken together, our data suggest that interactions between box A and the C-terminal tail
induce a conformation that is required for DNA bending.

High-mobility group (HMG)1 proteins are relatively
abundant non-histone nuclear proteins with one or more
homologous HMG-box DNA binding domains (1, 2). The
HMG box is ∼80 amino acids long and adopts an L-shaped
fold composed of three R-helices (3-9). DNA binding occurs
from the minor groove through partial intercalation of one
or two conserved hydrophobic residues, resulting in a sharp
DNA bend and helical underwinding. HMGB proteins also
bind preferentially to distorted DNA such as four-way
junctions, constrained minicircles, or DNA modified by the
anticancer agent cisplatin [cis-diamminedichloroplatinum(II)] (6, 10, 11).
Members of the protein family are subdivided according
to their function and specificity of DNA binding, with
moderately sequence-specific members including transcrip†
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tion factors such as sex-determining factor SRY and lymphoid enhancer factor LEF-1, while the non-sequencespecific family is represented by architectural chromatinassociated factors HMGB1 and -2. HMGB1 and -2 proteins
have been implicated in numerous DNA-dependent activities,
including DNA replication, repair, recombination, and
transcription due to their ability to promote formation of
higher-order nucleoprotein complexes (1, 2).
Vertebrate HMGB1 contains two HMG domains, termed
box A and box B, followed by an acidic C-terminal extension
which modulates DNA recognition. While the acidic tail
lowers the DNA binding affinity for most DNA substrates,
it appears to have little effect on binding to DNA minicircles
(12, 13). It was not established whether this is a consequence
of interaction of the tail with the HMG box(es) or the basic
N-terminal extension, or if it is simply charge repulsion;
however, the interaction of the C-terminal tail with one of
the HMG boxes, and the absence of interaction between
HMG domains, have been reported (14-16). In contrast, a
basic N-terminal extension of the yeast HMGB homologue
NHP6A is required for stable complex formation on both
linear DNA and DNA minicircles, and basic C-terminal
extensions stabilize binding of HMG-D and LEF-1 by
binding in the major groove opposite the distorted minor
groove (3, 17, 18). Thomsen et al. showed that interactions
of the basic N-terminal and acidic C-terminal domains of
maize HMGB1 may contribute to regulation of DNA
interactions, and a similar phenomenon was observed for
Arabidopsis HMGB1 and HMGB4 (19). This led the authors

10.1021/bi0522798 CCC: $33.50 © 2006 American Chemical Society
Published on Web 02/21/2006

3636 Biochemistry, Vol. 45, No. 11, 2006
to argue that interaction of the variable terminal domains of
plant HMGB proteins could serve as a molecular mechanism
involved in the fine-tuning of the functional properties of
these architectural proteins, depending on the structural
requirements of specific nucleoprotein complexes.
Saccharomyces cereVisiae contains four HMGB homologues; NHP6A and -B, which contain a single HMG box,
and HMO1 and -2, which more closely resemble vertebrate
homologues by having two domains in the positions corresponding to box A and box B. For HMO1, the box A domain
diverges significantly from HMG consensus sequences and
is not predicted to adopt the classical HMG fold, while box
B conforms more closely to the consensus. These two
domains are followed by ∼60 residues characterized by a
lysine-rich C-terminus. HMO1 appears to be involved in the
maintenance of chromatin integrity, as indicated by enhanced
plasmid loss rates and nuclease-sensitive chromatin in hmo1
knockout strains (20). HMO1 has also been shown to
participate in mutagenesis control and in regulation of rDNA
transcription (perhaps serving a function akin to that of
mammalian UBF which contains six HMG domains) and to
interact with the peptidyl-prolyl cis-trans isomerase FKBP12
(21-23). We have previously described the contribution of
both box A and box B to DNA binding in vitro (24). We
are reporting here the roles of each domain in DNA binding
and bending. In contrast to classical two-HMG box proteins,
our data suggest that box A and box B do interact with each
other and that the basic C-terminal tail primarily interacts
with box A. Surprisingly, the basic tail does not increase
the DNA binding affinity for either linear or four-way
junction DNA but is required for DNA bending by HMO1.
MATERIALS AND METHODS
Cloning and Purification of Proteins. Cloning of HMO1
and HMO1-boxA into pET28b for expression with an
N-terminal His6 tag was reported previously (24). Using a
PCR-based site-directed mutagenesis approach with pET28bHMO1 as a template, as described for generation of HMO1boxA (24), the codon specifying Ala210 was replaced with
a stop codon to create pET28b-HMO1-boxAB, carrying the
gene encoding the truncated protein HMO1-boxAB using
the forward primer 5′-TTACAGCACGCCTGAGAACCTCCT-3′ (stop codon underlined) and the reverse primer 5′ACTGAAAGGAATTGGAACCGGCGCAT-3′. DNA encoding HMO1-boxBC was amplified from pET28b-HMO1
using the forward primer 5′-GATCCACATATGCCAAAGAAG-3′ and the reverse primer 5′-ATCCGGATATAGTTCCTCCTT-3′, where an NdeI site (underlined) introduces
a methionine in place of Ala105. To create plasmid pET5aHMO1-boxBC, the amplified DNA was digested with NdeI
and cloned into pET5a. Using PCR-based site-directed
mutagenesis with pET5a-HMO1-boxBC as a template and
the same primers that were used for generation of pET28bHMO1-boxAB, the residue corresponding to the original
Ala210 was replaced with a stop codon to create pET5aHMO1-boxB.
Purification of N-terminally His6-tagged HMO1 and
HMO1-boxA was performed as described previously (24).
Plasmids carrying genes encoding the remaining HMO1
domains were transformed into Escherichia coli Rosetta
Blue. Cultures were grown to an A600 of ∼0.4, and expression
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was induced with 1 mM isopropyl β-D-thiogalactopyranoside
(IPTG) for 3 h. For purification of N-terminally His6-tagged
HMO1-boxAB, cells were pelleted, resuspended in dialysis/
lysis buffer at pH 7 [50 mM NaxHyPO4, 300 mM NaCl, 10
mM imidazole, 10% glycerol, 1 mM 2-mercaptoethanol, and
1 mM phenylmethylsulfonyl fluoride (PMSF)], and disrupted
by sonication. Nucleic acids were digested by addition of
DNase I followed by a 1 h incubation on ice. The lysate
was supplemented with EDTA-free Complete (Roche
Diagnostics) and passed through a nickel-nitrilotriacetic acid
column equilibrated with dialysis/lysis buffer and washed
with 5 column volumes of wash buffer at pH 7 (50 mM
NaxHyPO4, 300 mM NaCl, 20 mM imidazole, 10% glycerol,
1 mM 2-mercaptoethanol, and 1 mM PMSF). Proteins were
eluted with a 50 mL linear gradient from 20 mM imidazole
(wash buffer) to 250 mM imidazole (elution buffer, 50 mM
NaxHyPO4, 300 mM NaCl, 250 mM imidazole, 10% glycerol,
1 mM 2-mercaptoethanol, and 1 mM PMSF) followed by
100 mL of elution buffer.
For purification of untagged HMO1-boxBC, cells were
resuspended in lysis buffer [50 mM Tris-HCl (pH 8.0), 1 M
NaCl, 5% glycerol, 5 mM EDTA, 1 mM 2-mercaptoethanol,
and 1 mM PMSF]. Cells were disrupted by sonication and
nucleic acids digested by addition of DNase I followed by a
1 h incubation on ice. The extract was clarified by centrifugation at 5000g for 20 min. Cell lysates were dialyzed against
HA buffer at pH 8.8 (20 mM Tris-HCl, 50 mM KCl, 10%
glycerol, 1 mM EDTA, 4 mM 2-mercaptoethanol, and 1 mM
PMSF). The dialysate was passed through tandem columns
of DEAE-cellulose and CM-Sepharose equilibrated with the
same buffer. HMO1-boxBC was eluted with a 100 mL linear
gradient from 50 mM KCl (HA buffer) to 1 M KCl [HB
buffer; 20 mM Tris-HCl, 1 M KCl, 10% glycerol, 1 mM
EDTA, and 4 mM 2-mercaptoethanol, supplemented with
one tablet of EDTA-free Complete (Roche Diagnostics)].
Peak fractions were judged to be >95% pure by Coomassie
Blue-stained SDS-PAGE gels. For purification of untagged
HMO1-boxB, cells were lysed as described for HMO1boxBC, and cell lysates were dialyzed against HA buffer at
pH 8.3. The dialysate was purified on heparin-agarose
beads, and peak fractions eluted with a gradient from 50 mM
KCl (HA buffer) to 1 M KCl (HB buffer at pH 8.3) were
pooled and dialyzed against HA buffer at pH 7.0 (replacing
Tris-HCl with 50 mM NaxHyPO4) and passed through a
heparin-agarose column equilibrated with the same buffer;
>95% pure HMO1-boxB was eluted and analyzed as
described above. Purified proteins were quantitated on
Coomassie Blue-stained SDS-PAGE gels using bovine
serum albumin as a standard. Cross-linking in solution was
performed by incubation of 0.5 µg of protein with 1-ethyl
3-[3-(dimethylamino)propyl]carbodiimide (EDAC, prepared
fresh as a 10 mg/mL solution in water) for 30 min at room
temperature or with 0.1% glutaraldehyde for 10-30 min
followed by analysis of cross-linked products on SDSPAGE gels.
Circular Dichroism Spectroscopy. CD spectra were recorded on an AVIV model 202 CD spectrophotometer using
a 1 cm path length sample cell. Wavelength scans from 200
to 240 nm were performed in triplicate, and data points were
averaged and smoothed using standard methods. The wavelength scan shown for HMO1 was recorded at 25 °C with a
protein concentration of 0.007 mg/mL in buffer A [2.5 mM
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NaxHyPO4 (pH 7.0), 0.5% glycerol, and 10 mM NaCl]. The
wavelength scan for HMO1-boxA was recorded at 4 °C with
a protein concentration of 0.05 mg/mL in buffer B [1 mM
Tris-HCl (pH 7.0), 0.03% Tween 20, 10% glycerol, and 2.8
mM KCl].
The thermal stability of HMO1, HMO1-boxA, HMO1boxAB, HMO1-boxBC, and HMO1-boxB was measured
using the AVIV model 202 CD spectrophotometer and a 1
cm path length sample cell. HMO1, HMO1-boxAB, HMO1boxBC, and HMO1-boxB were diluted to 0.025 mg/mL in
CD buffer [50 mM NaxHyPO4 (pH 8.0), 10% glycerol, 200
mM NaCl, and 0.05% Tween 20]. HMO1-boxA was diluted
to 0.05 mg/mL in CD buffer. Thermal denaturation of HMO1
and HMO1-boxAB was also assessed in CD buffer at pH
7.0 (Tween 20 was omitted for HMO1). Temperaturedependent ellipticity measurements from 221 to 224 nm were
recorded from 4 to 90 °C (2 °C intervals), and wavelength
scans from 200 to 240 nm were obtained at 4 and 90 °C to
assess secondary structure and confirm the folded and
unfolded states. Reverse scans were performed at the same
wavelengths from 90 to 4 °C (0.5 °C intervals) to assess the
reversibility of unfolding. Ellipticity measurements were
corrected for buffer effects. For all proteins except HMO1boxAB, plots of the ellipticity values from 221 to 224 nm
versus the corresponding temperatures were fit to a twostate model for protein denaturation (25). For HMO1-boxAB
and HMO1 at pH 7.0, the plateau between the two transitions
of the biphasic melting curve was estimated visually, and
the plots were divided into single-transition plots to allow
fitting to the two-state model. Fits were performed using
KaleidaGraph. Melting temperatures (Tm) and the error of
the fits are reported using the ellipticity measurements at
222 nm. All experiments were performed at least in duplicate.
Electrophoretic Mobility Shift Assays. Oligonucleotides
were purchased and purified by denaturing gel electrophoresis. Four-way junctions were constructed and their integrities
confirmed as we described previously (24). Briefly, the fourway junction was prepared by annealing the four strands,
followed by purification of the junctions on native polyacrylamide gels. To ensure that all oligonucleotides were
present, aliquots of the purified junctions were run on
denaturing gels. EMSAs were performed as described
previously (24) with 5 fmol of 32P-labeled DNA and varying
amounts of HMO1 variants. Complexes were resolved on
prerun 7% (w/v) native polyacrylamide gels (39:1 acrylamide:bisacrylamide) at 4 °C with 0.5× TBE (50 mM Tris
borate and 1 mM EDTA). Quantitation was performed on
an Amersham Biosciences Storm Phosphorimager using
software supplied by the manufacturer. The fraction of bound
relative to total DNA was plotted as a function of protein
concentration and fitted to the microscopic Hill equation
bound/total ) {m[1/(KdnH)(L)nH]}/[1 + (1/KdnH)(L)nH], where
m represents maximal saturation, to obtain the microscopic
Hill Kd, reflecting half-maximal saturation of the DNA (the
aggregate affinity for the DNA probe), and the Hill coefficient (nH). Note that the aggregate affinities do not reflect
actual binding constants for the reactions composed of several
equilibria, each characterized by individual binding constants,
and are only semiquantitative comparisons. Fits were performed using KaleidaGraph, and the quality of the fits was
evaluated by visual inspection, χ2 values, and correlation
coefficients. All experiments were performed at least in
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triplicate, and values are reported as the mean ( the standard
deviation.
To generate 26 or 18 bp duplex DNA, complementary
oligonucleotides were mixed at equimolar concentrations,
heated at 90 °C, and slowly cooled to room temperature.
The sequence of the 26 bp duplex was 5′-CGTGACTACTGTAAGTCGATGATCCG-3′, and that of the 18 bp DNA
was 5′-CCTAGGCTACACCTACTC-3′. EMSAs were performed as described above with 5 fmol of DNA. Data were
quantitated as described above and fitted to the microscopic
Hill equation. All experiments were performed at least in
triplicate, and values are reported as the mean ( the standard
deviation.
For competition assays involving DNA minicircles, pET5a
was digested with BspHI to generate a 105 bp fragment. The
DNA was 5′-end labeled with T4 polynucleotide kinase, and
intramolecular ligation was accomplished by incubation with
T4 DNA ligase and Thermotoga maritima HU for 2 h at
room temperature (26). Linear DNA was removed by treating
the sample with exonuclease III for 1 h at room temperature,
followed by purification of cyclized DNA on a 6% (w/v)
native polyacrylamide gel. EMSAs were performed as
described above with 5 fmol of DNA. For competition,
cyclized 105 bp DNA and HMO1 were incubated for 30
min followed by addition of the indicated amount of
supercoiled pUC18.
For EMSAs with phosphorylated proteins, 15 pmol of
HMO1 variants was incubated with 500 units of tetrameric
CKII (New England Biolabs) and 2 mM ATP in the buffer
supplied by the manufacturer for 1 h at room temperature.
Parallel reactions were performed without ATP. Proteins
were diluted to the indicated concentrations and incubated
with 5 fmol of four-way junction DNA, and reactions were
resolved and visualized as described above. Confirmation
of phosphorylation was performed by including [γ-32P]ATP
in the reactions, followed by analysis on SDS-PAGE gels.
Gels were stained with Coomassie Blue for identification of
protein, and phosphorylation was detected by phosphoimaging.
Ligase-Mediated Cyclization. Ligation substrates were
prepared by digestion of pET5a with BspHI to generate a
105 bp fragment. DNA was 5′-end-labeled with T4 polynucleotide kinase and [γ-32P]ATP. Reactions were initiated
by addition of 20 units of T4 DNA ligase to a final volume
of 100 µL of reaction buffer [20 mM Tris-HCl (pH 8), 50
mM NaCl, 10 mM MgCl2, 0.1 mM Na2EDTA, 1 mM DTT,
and 0.05% BRIJ58] containing 1200 fmol of DNA, with or
without the protein. Time points were taken at intervals of
30 min. For each time point, 8 µL of the reaction mixture
was quenched by addition of 5 µL of stop buffer [75 mM
EDTA, 15% glycerol, 0.1% bromophenol blue (BPB), 0.1%
xylene cyanol, and 6 µg/µL proteinase K]. Samples were
heated at 55 °C for 15 min and resolved on prerun 7% (w/
v) native polyacrylamide gels (39:1 acrylamide:bisacrylamide) at 4 °C with 0.5× TBE. Cyclized DNA was identified
by its resistance to digestion with exonuclease III. Ligation
products were visualized by phosphorimaging.
RESULTS
Design of HMO1 Variants. For analysis of domain
functions and domain-domain interactions in HMO1, we
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FIGURE 1: Domain organization of HMO1. (A) HMO1 is composed
of HMG domains box A and box B, followed by a lysine-rich
C-terminal extension (C). Truncated HMO1 variants analyzed in
this work are listed. (B) HMO1 variants were purified to >95%
homogeneity. Purified proteins, HMO1-box A (lane A) and HMO1boxB (lane B), were analyzed on a 15% SDS-PAGE gel (left
panel), and HMO1-boxBC (lane BC), HMO1-boxAB (lane AB),
and the full-length protein were analyzed on a 12% gel (right panel).
Molecular mass markers are given at the left (in kilodaltons).

generated several truncated variants. HMO1-boxA spans the
short (11 amino acids) basic N-terminal extension, residues
Ala12-Ala90, comprising the HMG-like domain, and the
basic interdomain linker (residues Pro91-Ala105). HMO1boxB starts at Pro106, the first residue of the box B HMG
domain which ends at Leu179, and includes residues
Glu180-Ala209 of the C-terminal extension; the remaining
residues of the C-terminal tail comprise the lysine-rich
sequence. HMO1-boxBC includes box B and the entire
C-terminal tail, while HMO1-boxAB is deleted only for the
lysine-rich segment. All proteins were purified to apparent
homogeneity (Figure 1). DNA binding by untagged and
N-terminally His6-tagged HMO1 was previously compared,
and the tag was found not to modulate DNA interaction (24).
Experiments reported here were performed with His6-tagged
HMO1, HMO1-boxAB, and HMO1-boxA, while HMO1boxBC and HMO1-boxB were untagged.
Potential association in solution between HMO1-boxA and
HMO1-boxB was analyzed by chemical cross-linking using
carbodiimide which activates carboxyl groups for direct
amide bonding to primary amino groups; this reagent was
chosen as the theoretical pI of box A is 4.1. While some
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dimerization of HMO1-boxA was seen (consistent with the
previously reported ability of HMO1 to self-associate; 21),
no cross-linking of HMO1-boxA to HMO1-boxB (whether
the lysine-rich tail was present) was detectable (data not
shown). Similar results were obtained when glutaraldehyde
was used for cross-linking (of lysines). However, this does
not exclude interaction between these domains, as only
species properly oriented for the reagent to react will be
captured.
Interaction with Linear and Four-Way Junction DNA.
DNA binding by HMO1 variants was analyzed using
electrophoretic mobility shift assays (EMSAs). While HMO1
forms two detectable complexes with 26 bp DNA under these
conditions (Figure 2A), HMO1-boxA fails to associate stably
(not shown and ref 24). Surprisingly, removal of the lysinerich tail results in formation of a more stable complex by
HMO1-boxAB and a distinct migration pattern of complexes
(Figure 2B). Fits of fractional complex formation to the Hill
equation suggest positive cooperativity and little difference
in affinity between HMO1 and HMO1-boxAB (half-maximal
saturation at 26.5 and 31.9 nM, respectively; Table 1). While
Scatchard plots show curvature consistent with positive
cooperativity (not shown), we note that as the total length
of the DNA is relatively short, apparent negative cooperativity is seen at higher protein concentrations as it becomes
increasingly difficult to saturate the DNA probe (a statistical
effect, not necessarily reflecting modification of adjacent
binding sites). The “competing” effects of cooperativity of
protein binding and end effects associated with the length
of the DNA probe require that the reported Hill coefficients
be considered qualitative comparisons. As reported previously, HMO1 has only a modest preference for four-way
junction DNA compared to the linear duplex (half-maximal
saturation at 10.4 nM; Figure 3A and Table 1) (24). This
modest preference is also exhibited by HMO1-boxAB (halfmaximal saturation at 18.4 nM; Figure 3B).
Removal of the box A domain and the interdomain linker
to generate HMO1-boxBC results in a modest decrease in
affinity for linear 26 bp DNA (half-maximal saturation at
50.3 nM; Figure 2C) but retention of a pattern of complexes
similar to that seen for full-length HMO1. In contrast, the
additional truncation of the lysine-rich tail to generate
HMO1-boxB appears to change the stoichiometry of binding
to 26 bp DNA, although no change in the overall affinity is
evident (half-maximal saturation at 54.5 nM; Figure 2D).
This change in the stoichiometry of binding is particularly
evident with four-way junction DNA, with which both
HMO1-boxBC and HMO1-boxB, in particular, form numerous complexes (Figure 3C,D). Both proteins bind preferentially to four-way junctions compared to linear DNA, with

Table 1: HMO1 Variantsa
[Θ]MRW

Tm (°C)

Kd(26 bp)

nH

Kd(4WJ)

nH

HMO1
HMO1-boxAB

-17693
-14542

26.5 ( 1.1
31.9 ( 1.1

1.6 ( 0.1
2.4 ( 0.2

10.4 ( 0.5
18.4 ( 0.5

1.8 ( 0.2
2.5 ( 0.2

HMO1-boxA
HMO1-boxB
HMO1-boxBC

-11206
-14687
-13469

47.9 ( 0.1
46.0 ( 0.4
63.3 ( 0.5
57.2 ( 0.1
47.2 ( 0.1
46.1 ( 0.1

ncb
54.5 ( 2.9
50.3 ( 3.0

1.1 ( 0.1
1.0 ( 0.1

ndc
14.4 ( 0.3
10.1 ( 0.4

3.3 ( 0.2
1.8 ( 0.1

a
The mean residue molar ellipticity ([Θ]MRW) is reported at 222 nm and 4 °C (degrees square centimeter per decimole). The Hill Kd (in nanomolar)
represents half-maximal saturation of the DNA probe, and nH is the Hill coefficient. b No complex. c Not determined (low-affinity binding leading
to overly rapid complex dissociation during electrophoresis for reliable determination).
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FIGURE 2: Electrophoretic analysis of 26 bp DNA titrated with HMO1 variants. Reaction mixtures contained 5 fmol of DNA and increasing
concentrations of HMO1 (A), HMO1-boxAB (B), HMO1-boxBC (C), or HMO1-boxB (D). Free DNA and complexes are identified at the
right. Reaction mixtures in lane 1 contained DNA only. Reaction mixtures in lanes 2-15 contained 10, 20, 30, 45, 65, 80, 100, 200, 500,
800, 1000, 2000, 3500, and 7500 nM protein, respectively (panels A and B), or 10, 25, 50, 75, 100, 125, 150, 200, 500, 1000, 2000, 3000,
4000, and 6000 nM protein, respectively (panels C and D). (E and F) Binding isotherms for binding of HMO1 and HMO1-boxBC to 26
bp DNA. When error bars are not shown, they are smaller than the size of the symbol.

half-maximal saturation at 10.1 and 14.4 nM, respectively.
While the overall affinity of the HMO1 variants appears to
change little upon removal of box A, the stoichiometry of
binding changes appreciably, consistent with a contribution
of box A to DNA interaction. Removal of the lysine-rich
tail from HMO1-boxBC primarily results in formation of
additional retarded species, while its removal from HMO1
results in formation of a more stable complex, particularly
with linear DNA.

HMO1 was previously shown to exhibit a longer residence
time on DNA minicircles compared to linear or supercoiled
DNA (24). While HMO1-boxAB exhibits a distinct pattern
of complex formation with DNA minicircles, the lysine-rich
tail appears not to be required for preferred binding to the
minicircle DNA, as evidenced by the inability of supercoiled
plasmid DNA to compete effectively for binding (Figure 4,
top panels). In contrast, both HMO1-boxB and HMO1boxBC are more effectively forced off the minicircle by
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FIGURE 3: Electrophoretic analysis of four-way junction DNA titrated with HMO1 variants. Reaction mixtures contained 5 fmol of DNA
and increasing concentrations of HMO1 (A), HMO1-boxAB (B), HMO1-boxBC (C), or HMO1-boxB (D). Free DNA and complexes are
identified at the right. Reaction mixtures in lane 1 contained DNA only. Reaction mixtures in lanes 2-13 contained 5, 7.5, 10, 15, 20, 25,
30, 50, 100, 200, 400, and 800 nM protein, respectively (panels A and B), 5, 7.5, 10, 15, 25, 50, 100, 200, 400, 800, and 1000 nM protein,
respectively (panel C), or 5, 7.5, 10, 12.5, 15, 17.5, 20, 30, 60, 100, 200, 500, and 1000 nM protein, respectively (panel D). (E and F)
Binding isotherms for binding of HMO1 and HMO1-boxBC to four-way junction DNA. When error bars are not shown, they are smaller
than the size of the symbol.

addition of supercoiled DNA, indicating that box A is
required for preferred binding to the constrained minicircle
(bottom panels).
Box A and the C-Terminal Tail Are Required for DNA
Bending. DNA bending was assessed using a ligase-mediated
cyclization assay in which 105 bp DNA was cyclized with

T4 DNA ligase in the presence of HMO1 variants. HMO1
promotes the formation of constrained minicircles, as evidenced by their resistance to digestion with exonuclease III,
an indication of its ability to bend the DNA duplex (Figure
5, top left panel). Notably, the ability to bend DNA is
effectively abolished with removal of the lysine-rich tail
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FIGURE 4: Box A domain that is required for preferred binding to
circular DNA. Five femtomoles of cyclized 105 bp DNA was
incubated with the indicated HMO1 variant (500 nM) followed by
addition of supercoiled pUC18. Reaction mixtures in lane 1 contain
no HMO1. Reaction mixtures in lanes 2 and 8 contain no competitor
DNA (pUC18). Reaction mixtures in lanes 3-7 and 9-13 contain
1, 5, 10, 50, and 100 fmol of pUC18, respectively.

FIGURE 5: Time course ligation of 105 bp DNA. DNA was
incubated with the indicated HMO1 variants (50 nM) and T4 DNA
ligase. Lane 1 contained no ligase. Lanes 2-8 represent time points
taken at 0.5, 1, 2.5, 5, 10, 20, and 30 min, respectively. Reaction
mixtures in lane 9 were incubated with ligase for 30 min followed
by treatment with exonuclease III for 30 min.

(HMO1-boxAB, top right panel) or box A (HMO1-boxBC,
bottom left panel); the monomeric circle comigrates with
the linear trimer, as evidenced also by the observation that
cyclization of 105 bp DNA in the absence of any HMO1
fragment produces this exonuclease III-sensitive species (24).
No DNA cyclization was seen in the presence of HMO1boxB or HMO1-boxA (not shown). The failure of HMO1boxA and HMO1-boxBC to assemble into a functional
conformation is evidenced by the inability to restore DNA
bending after co-incubation of the two fragments (bottom
right panel). Evidently, DNA bending by HMO1 requires
the presence of both box A and the lysine-rich tail in a single
polypeptide.
Thermal Stability of HMO1 Domains. DNA cyclization
assays raise the possibility that an interaction between box
A and the C-terminal tail is required for functional activity.
We therefore further explored domain-domain interactions
by circular dichroism (CD) spectroscopy. All proteins were
found to exhibit significant R-helical content as evidenced
by negative ellipticities at 208 and 222 nm (ref 24 and data
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not shown). To measure thermal stability, ellipticity measurements at four wavelengths spanning the negative ellipticity minimum of 222 nm were recorded over the temperature range of 4-90 °C and fitted to a modified van’t Hoff
equation for a two-state unfolding equilibrium (Figure 6).
At 4 °C, the amplitude of the negative mean residue molar
ellipticity ([Θ]MRW) at 222 nm is comparable for HMO1boxAB, HMO1-boxB, and HMO1-boxBC; that of full-length
HMO1 is significantly greater, and the amplitude of [Θ]MRW
for HMO1-boxA is lower (Table 1). These variations suggest
distinct secondary structure content. The CD melting curve
for full-length HMO1 reveals a sharp, single transition from
the native to a definitive denatured conformation with a
calculated melting temperature (Tm) of 47.9 °C, suggesting
a two-state unfolding equilibrium. For the individual box A
and box B domains, two-state unfolding transitions were also
seen, with Tm values of 57.2 and 47.2 °C, respectively, while
HMO1-boxBC melts at 46.1 °C. The comparable unfolding
transitions of HMO1-boxB and HMO1-boxBC may imply
little interaction between box B and the lysine-rich tail, while
the markedly higher Tm for HMO1-boxA compared to that
of full-length HMO1 suggests that interactions between box
A and box B or between box A and the lysine-rich tail induce
a less stable conformation of box A. In contrast, HMO1boxAB, truncated for the lysine-rich extension, exhibits a
biphasic transition from the native to the denatured state with
Tm values of 46.0 and 63.3 °C, consistent with the presence
of two distinct domains and suggesting that the destabilization of box A seen in full-length HMO1 is primarily due to
interactions between box A and the tail. Two unfolding
transitions were also observed for HMO1-boxAB at pH 7.0
(Tm values of 48.2 ( 2.0 and 71.7 ( 0.7 °C; not shown).
Notably, HMO1 also exhibited biphasic unfolding at pH 7.0
with Tm values of 23.5 ( 0.4 and 57.6 ( 0.8 °C (Figure 6,
bottom right panel). As discussed below, the low-temperature
transition is most likely due to unfolding of the C-terminal
tail. While some secondary structure was seen on refolding
of the proteins, the original secondary structure was not
recovered, as judged by wavelength scans (not shown).
Phosphorylation Modulates Domain-Domain Interactions. HMGB proteins have been reported to serve as
substrates for casein kinase II (CKII) (19, 27-29). Analysis
of the HMO1 sequence using Scansite, which predicts
optimal phosphorylation sites for specific protein Ser/Thr
kinases using a matrix of selectivity values for amino acids
at each position relative to the phosphorylation site (30, 31),
predicts two sites for CKII. One site, Ser153, is located in
box B, in the loop between helices II and III (Figure 7),
while the other is in the C-terminal tail (Ser225). We used
this information as an additional tool to monitor interactions
between domains. HMO1 is indeed a substrate for CKII
(Figure 8A), and phosphorylation of all fragments except
HMO1-boxA is seen; phosphorylation reduces the positive
charge and causes a faster migration compared to that of
the unphosphorylated protein (compare Figures 1B and 8A).
The observed difference in migration is therefore what would
be expected. Second, Coomassie staining of the gels confirms
that the stained bands correspond to those identified by
phosphorimaging (not shown), arguing against the existence
of labeled contaminants (as none of the protein preparations
contain abundant contaminants, Figure 1). We also note that
a single labeled species is seen for HMO1-boxB (band 5),
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FIGURE 6: Thermal unfolding transitions of HMO1 variants. Ellipticity measurements were collected from 4 to 90 °C at four wavelengths
(221-224 nm) spanning the negative ellipticity maximum characteristic of R-helices; results recorded at pH 8.0 and 222 nm are shown for
all variants. The bottom right panel shows thermal unfolding at all four wavelengths of 0.06 mg/mL HMO1 recorded at pH 7.0.

while two bands appear for HMO1-boxBC (bands 4 and 5).
As HMO1-boxB is certainly at least monophosphorylated
to be detectable by phosphorimaging, HMO1-boxBC must
carry at least one additional phosphate to compensate for
the difference in migration of the unphosphorylated proteins

(Figure 1). Likewise, a single phosphorylated species is
detected for HMO1-boxAB (band 3), while HMO1 is
phosphorylated at two sites [bands 2 and 3; the doubly
phosphorylated HMO1 and singly phosphorylated HMO1boxAB comigrate with the autophosphorylated 26 kDa CKII
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FIGURE 7: Model of box B generated with SwissModel. A predicted
phosphorylation site in the loop between helices II and III is colored
green. Residues colored red are predicted to contact DNA. Helices
are identified with Roman numerals. This illustration was generated
with PyMol.

subunit, as shown by Coomassie staining of SDS-PAGE
gels (not shown); the level of phosphorylation of CKII
subunits is reduced in the presence of an exogenous
substrate]. The simplest explanation is therefore that the
observed phosphorylated species correspond to phosphorylation at the predicted sites, one in box B and one in the
C-terminus.
Analysis of DNA binding shows that phosphorylation of
HMO1-boxB has no effect (Figure 8B), while the extent of
DNA binding by the other phosphorylated HMO1 variants
is reduced (Figure 8C-E), as indicated by a lower fractional
saturation of the DNA probes with the phosphorylated
HMO1 variant. The location of Ser153 opposite the DNAbinding interface of box B (Figure 7) is consistent with
phosphorylation of HMO1-boxB having no effect on DNA
binding. The reduced level of DNA binding seen for
phosphorylated HMO1-boxBC therefore suggests that phosphorylation of the C-terminus causes the observed effect,
and that the C-terminus contacts DNA or the DNA-binding
interface of box B. Notably, phosphorylated HMO1-boxAB
also exhibits a reduced level of DNA binding. As DNA
binding by the isolated box B domain is unaffected by
phosphorylation, we interpret the weakened DNA interaction
of phosphorylated HMO1-boxAB in terms of attenuated
interactions between boxes A and B.
DISCUSSION
Domain-Domain Interactions in HMO1. While box B
conforms to consensus HMG sequences, the sequence of box
A differs from the consensus and includes a five-amino acid
insertion in helix III. This insertion contains a helix-breaking
glycine and may therefore alter the conformation of the
folded domain, consistent with the lower amplitude of
[Θ]MRW for HMO1-boxA (Table 1). A different conformation
is also consistent with the differential thermal stability. The
comparable [Θ]MRW for HMO1-boxAB and HMO1-boxB
suggests that interactions between box A and box B (or the
portion of the C-terminal fragment included in HMO1-boxB)
increase the helical content of box A. A change in the
conformation of box A on association with box B is also
suggested by the increase in the Tm for the box A domain
from ∼57 to 63 °C (Figure 6). Assuming that HMO1 is

FIGURE 8: HMO1 variants phosphorylated by casein kinase II. (A)
SDS-PAGE gel showing phosphorylation of HMO1-boxB (B),
yielding a single phosphorylated species identified as band 5,
HMO1-boxBC (BC), resulting in two species marked 4 and 5,
HMO1-boxAB (AB) comigrating with the autophosphorylated CKII
subunit (marked 3), and HMO1 (wt), yielding two phosphorylated
species marked 2 and 3. HMO1-boxA is not a substrate for CKII.
Lane 1 contained CKII only, with bands marked 1 and 3
representing autophosphorylated 26 and 44 kDa subunits, respectively. (B) DNA binding by phosphorylated HMO1 variants. EMSA
with 5 fmol of four-way junction DNA and the indicated HMO1
variant. Results with the unphosphorylated protein are shown in
the left panels and results with the phosphorylated protein in the
right panels. Reaction mixtures in lane 1 contained no protein.
Protein concentrations, identical for all panels, are 12.5, 25, 50,
100, and 150 nM.

indeed phosphorylated at the predicted sites, phosphorylation
of HMO1-boxAB would occur in the loop connecting box
B helices II and III; as this phosphorylation does not
modulate DNA binding by HMO1-box B (Figure 8B), but
attenuates DNA binding by HMO1-boxAB, we surmise that
the observed interaction occurs between boxes A and B.
Interactions between box A and box B are consistent with
the theoretical pI of the isolated box A domain (excluding
the N-terminal residues and the basic interdomain linker) of
4.1 and the pI of box B of 9.1. This observation is distinct
from that for vertebrate HMGB1, for which no association
between HMG domains was evident (14, 15, 32, 33).
The lysine-rich segment of the C-terminal tail also
associates with box A. This is evident from the significant
decrease in the thermal stability of the box A domain in fulllength HMO1 compared to that of HMO1-boxA or HMO1boxAB (Figure 6). For HMO1, the good fit to a two-state
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unfolding model is consistent with coupled melting of both
domains. This evidently depends on the presence of the
lysine-rich tail, as the melting transition for HMO1-boxAB
is markedly different. The good fit to the two-state model
also implies that no intermediate state is significantly
populated during the thermal transition. A two-state unfolding
mechanism was also reported for vertebrate HMGB1 (14,
34).
We also note the increase in the magnitude of [Θ]MRW
for HMO1 compared to that of HMO1-boxAB which
indicates conformational changes associated with inclusion
of the lysine-rich tail. Since a comparable change in [Θ]MRW
is not associated with addition of the tail to HMO1-boxB
(rather, the [Θ]MRW reflects lower helical content for HMO1boxBC), we conclude that interactions between box A and
the tail are required for the observed conformational change.
That the box A domain does not unfold independently in
HMO1 is also indicated by the change in denaturation
enthalpy between HMO1-boxA and the full-length protein
(∆H° ) 27 kcal/mol for HMO1-boxA and 37 and 38 kcal/
mol for HMO1 and HMO1-boxB, respectively).
When thermal denaturation of HMO1 and HMO1-boxAB
was performed at pH 7.0, a main difference was the
appearance of a separate denaturation event for HMO1 with
a very low Tm of 23 °C (Figure 6). The lysine-rich tail would
exhibit less charge repulsion at pH 8.0 than at pH 7.0;
accordingly, this domain may fold more stably at pH 8.0,
which is reflected in the greater amplitude of [Θ]MRW for
full-length HMO1 and its single unfolding transition (Table
1), but undergo a separate transition to the unfolded state at
pH 7.0. While interactions between HMG boxes A and B
and between box A and the lysine-rich tail are indicated from
these analyses, the failure to restore DNA binding properties
of full-length HMO1 by association of individual fragments
suggests that proper association requires each domain to be
encoded on a single polypeptide. This contrasts with HMGB1
for which a peptide representing the acidic C-terminus
associates with the box AB fragment to restore the thermal
stability seen for the full-length protein, suggesting assembly
from isolated domains (16).
Mechanism of DNA Binding by HMO1. The box B domain
of HMO1 contributes significant DNA binding affinity (Table
1). However, it is interactions between box A and the lysinerich C-terminus that determine substrate specificity and DNA
bending (Figures 4 and 5). Evidently, the mode of contact
with DNA changes considerably with inclusion of the
C-terminal tail, as shown by the differential complex stability
and DNA bending by HMO1 and HMO1-boxAB. As
discussed above, significant conformational changes occur
in box A upon association with box B and the tail, and the
C-terminal domain appears to fold only upon association with
box A. In contrast, our data do not indicate significant
changes in the conformation or dynamics of box B upon its
association with other domains (both Tm and ∆H° are
essentially unaltered for HMO1-boxB, HMO1-boxBC, and
HMO1).
The HMG domain interacts with ∼10 bp of the DNA
duplex. This is consistent with the number of complexes seen
on 26 bp DNA with the isolated box B domain (Figure 2).
While an 18 bp duplex was previously shown not to support
formation of a stable complex with full-length HMO1 (24),
a single complex is seen with HMO1-boxAB (not shown);

Bauerle et al.
this indicates that both boxes A and B contact ∼10 bp of
the duplex and suggests that the additional complex seen
with 26 bp DNA may involve only the higher-affinity box
B interacting with the DNA and/or protein-protein contacts.
The pattern of complexes on four-way junction DNA is
consistent with preferential binding at the junction crossover,
leading to a compact complex with high mobility, while
additional complexes suggest progressive occupancy of the
junction arms.
The HMG domain binds to the minor grove of DNA by
partial intercalation of one or two surface-exposed, conserved
hydrophobic residues into the base pair stack. For vertebrate
HMGB1, the DNA-intercalating residues are located in
helices I and II, and both can contribute to binding affinity.
Our data show that HMO1, whose box B lacks the equivalent
hydrophobic residue in helix II (Ser138, Figure 7), has a
limited preference for distorted DNA. A modest preference
for four-way junction DNA is also seen for HMO1-boxB.
Structures of HMGB proteins in complex with four-way
junction DNA or platinated DNA show that the helix II
hydrophobic residue stacks on an exposed base pair and on
the second guanosine of the cisplatin adduct, respectively
(35-39). This results in a different disposition of the protein
with regard to the DNA bend compared with that of
sequence-specific proteins, e.g., SRY and LEF-1, whose
primary DNA-intercalating residue is in helix I. Recently, it
was also shown that NHP6A, which kinks duplex DNA using
its helix I residue as the primary bending wedge, uses its
helix II hydrophobic residue for selective recognition of
cisplatin-modified DNA (35). An argument against the
absolute requirement for a helix II hydrophobic residue for
recognition of four-way junctions or platinated DNA is that
SRY and LEF-1, which both have a polar residue at the
equivalent position of helix II, retain high-affinity binding
to both modified DNA constructs (36-39). The absence of
a helix II bending wedge in box B may predict an orientation
on DNA akin to that reported for SRY or LEF-1.
The effect of the lysine-rich tail on DNA binding is not
what would be predicted from simple electrostatics, pointing
to a change in the conformation or dynamics of the HMG
box(es) upon association with the tail, and consistent with
the observed changes in the secondary structure and stability
of box A. Evidently, the role of the lysine-rich tail in bending
is not based on affinity but is an intrinsic effect of the tail
on the mechanism of bending; whether this mechanism
involves direct contacts between the basic C-terminus and
the DNA or is based solely on conformational changes in
box A cannot be determined from these data. If box A is
induced to adopt a HMG-like conformation, then it would
possess potential intercalating bending wedges in both helices
I (Leu) and II (Ile), consistent with its ability to bend DNA.
The data presented here suggest that the functional
significance of the tripartite domain organization of HMO1
is the ability to modulate DNA bending without compromising complex stability. Our DNA binding experiments were
performed at pH 8.0, where HMO1 is more stable. In vivo,
a lower pH would be encountered, but molecular crowding
and interaction with cellular macromolecules may serve to
stabilize the protein compared to what is observed in dilute
solution in vitro (Figure 6). We would therefore anticipate
that the more stably folded conformation exists in vivo.
However, as the C-terminal domain appears to be only
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marginally stable at physiological pH and temperature, its
conformation may potentially be readily modulated by
covalent modification or by association with other cellular
factors, leading to differential DNA bending. Such properties
may explain the ability of HMO1 to serve as a general
chromatin-associated factor involved in the maintenance of
chromatin integrity by virtue of its long residence time on
DNA and at the same time to serve as a specific architectural
transcription factor in rDNA transcription.
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